Trump’s FDA Cuts Are Putting Drug Development at Risk

March 3, 2025 Caroline Haskins

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Previous Article
Nothing Phone (3a) and Phone (3a) Pro Review: Budget Excellence
Nothing Phone (3a) and Phone (3a) Pro Review: Budget Excellence

Nothing's latest budget phones prove that you don't need to spend $600 to get a powerful, feature-packed ph...

Next Article
Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies
Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

The DOGE-mandated credit card freeze is delaying shipments of critical supplies, stalling travel, and stopp...